CryoCell International Inc (CCEL) — Cash Flow Quality Index
CryoCell International Inc (CCEL) has a Cash Flow Quality Index of 3.38x as of August 2025. Operating cash flow of $2.54 Million exceeds net income of $749.41K, indicating high earnings quality where cash backs reported profits. Explore CCEL strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CryoCell International Inc Cash Flow Quality Index (1996–2024)
Historical Cash Flow Quality Index for CryoCell International Inc across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CCEL goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for CryoCell International Inc (1996–2024)
Year-by-year earnings quality comparison for CryoCell International Inc. For live market cap and the full company financial profile, see CryoCell International Inc (CCEL) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 14.95x | $6.01 Million | $402.10K | ▲ +383.3% |
| 2022 | 3.09x | $8.57 Million | $2.77 Million | ▼ -18.7% |
| 2021 | 3.80x | $7.93 Million | $2.08 Million | ▲ +62.9% |
| 2020 | 2.34x | $8.47 Million | $3.62 Million | ▼ -15.4% |
| 2019 | 2.76x | $6.32 Million | $2.29 Million | ▲ +11.8% |
| 2017 | 2.47x | $5.72 Million | $2.32 Million | ▲ +312.7% |
| 2015 | 0.60x | $4.85 Million | $8.11 Million | ▼ -78.7% |
| 2014 | 2.81x | $1.55 Million | $553.62K | ▼ -90.6% |
| 2013 | 29.96x | $821.98K | $27.44K | ▲ +4269.8% |
| 2010 | 0.69x | $2.34 Million | $3.41 Million | ▼ -73.9% |
| 2009 | 2.63x | $3.75 Million | $1.42 Million | ▼ -15.5% |
| 2005 | 3.11x | $3.22 Million | $1.03 Million | ▲ +90.3% |
| 2004 | 1.64x | $4.65 Million | $2.84 Million | ▲ +17.0% |
| 2001 | 1.40x | $1.26 Million | $899.63K | ▼ -30.1% |
| 1996 | 2.00x | $1.20 Million | $600.00K | — |